FDA's vaccine advisers to discuss rules for authorizing COVID-19 shots for kids

Vaccine advisers to the US Food and Drug Administration will meet Thursday to discuss what information the agency should ask for in considering the go-ahead...

Posted: Jun 9, 2021 10:48 AM
Updated: Jun 9, 2021 11:49 AM

Vaccine advisers to the US Food and Drug Administration will meet Thursday to discuss what information the agency should ask for in considering the go-ahead for vaccinating children under 12 -- including how many children need to be enrolled in clinical trials and how much safety data will be needed.

Members of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will not be asked to discuss specific vaccines or to vote on any issues, but instead will weigh in on what specific extra information companies will have to provide in seeking authorization or approval for children.

Pfizer's COVID-19 vaccine is currently authorized for people 12 and older in the US. Pfizer said Tuesday it would begin testing its vaccine in children as young as 5 using smaller doses than what is authorized for people 12 and older. The company said its Phase 2/3 trial will enroll up to 4,500 children in the United States, Finland, Poland and Spain.

Pfizer and its partner BioNTech also plan to start testing the vaccine in babies as young as 6 months in the coming weeks. But no approval or authorization is expected for younger children before the new school year starts at the end of summer.

Data about Moderna's Covid-19 vaccine for children as young as 5 will likely be available in September or October, Moderna told CNN, and the company plans to apply soon for FDA authorization for use of its vaccine in youths as young as 12.

The rollout has been quick in the younger age group; more than 3.5 million people ages 12 to 15 have already received at least one dose of the vaccine. Half of those 12 and older have now been fully vaccinated, according to data published Tuesday by the US Centers for Disease Control and Prevention.

But the FDA says it will be seeking more deliberate study for authorizing use of the vaccines in kids 11 and under.

Pfizer has applied for full approval, called a biologics license application or BLA, for its vaccine in people 12 and older. Moderna is expected to. So the committee members will be asked to consider what would be needed both for emergency use authorization in children, and full approval. The FDA has broken the younger children into three groups: 6 to 11, 2 to 6 and six months to 2 years.

"What I think we're going to do with that meeting is we're going to decide what the parameters are for approval -- either through emergency use authorization or for licensure -- for much younger age groups," VRBPAC committee member Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia, told CNN's Jake Tapper last week.

"Do we want a two-month follow up? Do we want a six-month follow up? What level of efficacy are we looking for?" Offit added. "It's those sort of parameters we'll be discussing."

In briefing documents released ahead of Thursday's meeting, the FDA said it's usually acceptable to use what are called immunobridging studies to justify approval or emergency authorization of vaccines in children.

These look for evidence of immunity based on what's seen in adults who have volunteered in clinical trials.

In the case of coronavirus vaccines, the FDA said, it would accept data on neutralizing antibodies -- the virus-attacking immune system proteins that are generated by vaccination. So instead of vaccinating a group of children and waiting to see if any become infected, companies could instead run blood tests to see if the vaccines generated an immune response.

Because Covid-19 has not caused the same level of serious disease in children as it has in adults, the FDA said companies will have to make a strong case for authorizing their use in children.

FDA usually asks for safety data in between 500 and 3,000 children in considering a new pediatric vaccine. "Since Covid-19 vaccines represent a new class of vaccines, with many of the lead candidates based on new platform technologies, an appropriate overall pediatric safety database would approach the upper end of this range," it said in the briefing documents.

"Emergency use authorization of a COVID-19 vaccine for use in pediatric populations would require a determination that the known and potential benefits of the vaccine outweigh the known and potential risks specifically in the age groups being considered for emergency use authorization," the FDA added.

"Therefore, clear and compelling evidence to support the safety of the vaccine would be expected to justify its authorization for emergency use in millions of healthy children."

Experts will be asked to consider the possibility of a phenomenon called vaccine-enhanced disease -- when vaccinated people get sicker when infected than unvaccinated people do. This happened in 2017 with a dengue vaccine used in the Philippines. So far, there's been no evidence coronavirus vaccines can cause this, the FDA noted.

Doctors will also be asked about the possibility of a condition called multisystem inflammatory syndrome in children or MIS-C, which is seen in some kids who have been infected with coronavirus and which is theoretically possible after vaccination, but hasn't been seen yet.

"Finally, the VRBPAC will be asked to discuss circumstances under which emergency use authorization could be considered for age groups within 6 months to 12 years and, in that context, data needed to support benefits of making COVID-19 vaccines available under emergency use authorization and safety data needed to assess risks," the FDA said.

New York Coronavirus Cases

County data is updated nightly.

Cases: 2109677

Reported Deaths: 53558
CountyCasesDeaths
Kings28056310454
Queens2772449955
Suffolk2010083400
Nassau1836243175
Bronx1834576588
New York1382444499
Westchester1296572290
Erie895721806
Richmond749601841
Monroe689591110
Orange48308843
Rockland46936963
Onondaga38928677
Dutchess29470445
Albany24696356
Oneida22614514
Niagara20033372
Broome18619366
Saratoga15362168
Ulster13907257
Schenectady13200205
Rensselaer11228142
Putnam1060592
Chautauqua8951145
Chemung7759136
Oswego762292
Ontario740593
Steuben6952144
Sullivan667276
St. Lawrence663796
Cayuga633792
Jefferson613168
Wayne578270
Cattaraugus572091
Genesee5435124
Herkimer5186109
Clinton483533
Madison456289
Livingston452060
Fulton442191
Tompkins434652
Montgomery4254126
Columbia4064104
Cortland392562
Tioga382963
Warren365857
Wyoming358153
Allegany355587
Chenango349876
Otsego346147
Greene340379
Washington316155
Orleans311883
Lewis280836
Franklin256312
Delaware237938
Seneca201156
Schoharie169217
Essex159326
Yates117826
Schuyler107414
Hamilton3132
Unassigned9211
Out of NY0249
Utica
Cloudy
62° wxIcon
Hi: 65° Lo: 54°
Feels Like: 62°
Oneonta
Cloudy
60° wxIcon
Hi: 63° Lo: 53°
Feels Like: 60°
Herkimer
Cloudy
62° wxIcon
Hi: 68° Lo: 55°
Feels Like: 62°
Old Forge
Cloudy
62° wxIcon
Hi: 64° Lo: 52°
Feels Like: 62°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
Enchanted Forest Water Safari Summer Fun Giveaway
Father's Day Giveaway 2021
Senior Send-Off brought to you by Herkimer College
18 Facets of Summer Photo Contest brought to you by Herkimer Diamond Mines
Looking for work or looking to hire? Check out the WKTV Job Fair!
Alivana Ready for Summer Giveaway
Saluting Those Who Are Proud 2 Serve